Evofem Biosciences, Inc. (NASDAQ:EVFM – Get Free Report) shares crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.01 and traded as low as $0.0075. Evofem Biosciences shares last traded at $0.0082, with a volume of 278,264 shares.
Evofem Biosciences Stock Down 5.7%
The firm has a market cap of $1.09 million, a P/E ratio of -0.01 and a beta of -1.25. The business’s 50 day moving average is $0.01 and its two-hundred day moving average is $0.01.
About Evofem Biosciences
Evofem Biosciences is a clinical‐stage biotechnology company based in San Diego, California, specializing in women’s sexual and reproductive health. Founded in 2013 as a spin-out of the Scripps Research Institute, the company is focused on developing non-hormonal, on-demand products that address unmet needs in contraception and the prevention of sexually transmitted infections.
The company’s lead commercial product, Phexxi, is an FDA-approved, non-hormonal vaginal gel that maintains the vagina’s natural pH to reduce the risk of unintended pregnancy.
Further Reading
- Five stocks we like better than Evofem Biosciences
- Why Alphabet’s Pullback May Be an Opportunity in Disguise
- Capri’s Turnaround Is Taking Shape, But Is the Stock a Buy Yet?
- SpaceX Has Real Value—But These 3 Stocks Have Better Odds Right Now
- 3 Stocks That Could Benefit as the Robotaxi Race Heats Up
Receive News & Ratings for Evofem Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evofem Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
